Shop
Accessories
Accessories
Cannabidivarin, a non-psychoactive cannabinoid being researched for potential anticonvulsant and neuroprotective effects.
Cannabidivarin, or CBDV, is a non-psychoactive cannabinoid closely related to CBD but with a shorter side chain. Found naturally in certain cannabis cultivars, CBDV is present in higher concentrations in landrace indica strains from northwest India and Nepal. It has become a focus of pharmaceutical research for neurological conditions.
GW Pharmaceuticals (now part of Jazz Pharmaceuticals) has conducted clinical trials investigating CBDV for epilepsy, particularly in conjunction with their existing CBD-based drug Epidiolex. Preclinical research has shown CBDV may reduce nausea through interaction with 5-HT1A serotonin receptors and TRPV1 channels. Studies have also explored CBDV for Rett syndrome and autism spectrum disorders, though these investigations remain in early stages. A 2019 study in the Journal of Psychopharmacology found that CBDV altered brain connectivity patterns in adults with autism.
CBDV is not yet widely available as a standalone consumer product, though it appears naturally in certain hemp-derived full-spectrum extracts. As research progresses and demand grows, some companies have begun offering CBDV-enriched products. For consumers interested in minor cannabinoids, checking detailed lab reports for CBDV content can help identify products that contain meaningful amounts of this compound.
DoseCraft
VapeHeatLab